Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of "Hold" by Analysts

Key Points

• Analysts' consensus: Ten analysts give Oscar Health a "Hold" rating (2 sell, 6 hold, 2 buy) with an average 1-year price target of about $16.88.
• Latest quarter missed expectations—EPS of ($1.24) vs. ($0.92) expected and revenue $2.81B vs. $3.12B expected—though revenue rose 17.3% year-over-year; shares recently traded around $12.76 with a 52-week range of $10.69–$23.80 and a market cap near $3.8B.
• Insider activity and ownership: CEO Mario Schlosser sold 23,038 shares at $17.65 (a 6.17% reduction in his position); insiders own 24.39% of the stock while institutional investors hold 75.70%.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been assigned a consensus recommendation of "Hold" from the ten ratings firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $16.8750.

OSCR has been the topic of several research reports. Barclays set a $18.00 target price on Oscar Health and gave the stock an "equal weight" rating in a research report on Monday, January 5th. Raymond James Financial upgraded Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 price target for the company in a research note on Thursday, February 12th. Weiss Ratings reiterated a "sell (d)" rating on shares of Oscar Health in a research note on Thursday, January 22nd. Stephens started coverage on Oscar Health in a research note on Thursday, December 11th. They set an "equal weight" rating and a $17.00 price target for the company. Finally, UBS Group reiterated a "neutral" rating and set a $15.00 price target on shares of Oscar Health in a research note on Wednesday, February 11th.

Insider Activity

In other news, insider Mario Schlosser sold 23,038 shares of the company's stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares in the company, valued at approximately $6,180,677. This represents a 6.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 24.39% of the company's stock.

Institutional Trading of Oscar Health

Large investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC boosted its stake in shares of Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company's stock worth $25,000 after acquiring an additional 1,282 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new stake in Oscar Health during the 1st quarter valued at approximately $30,000. Fifth Third Bancorp boosted its stake in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock valued at $34,000 after purchasing an additional 1,413 shares during the period. Finally, Quarry LP boosted its stake in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after purchasing an additional 1,469 shares during the period. Institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Shares of OSCR stock opened at $12.76 on Tuesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.96 and a quick ratio of 0.96. Oscar Health has a fifty-two week low of $10.69 and a fifty-two week high of $23.80. The stock's 50-day moving average is $13.16 and its two-hundred day moving average is $15.78. The firm has a market cap of $3.80 billion, a P/E ratio of -7.33 and a beta of 1.93.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The firm had revenue of $2.81 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same period in the previous year, the company earned ($0.62) earnings per share. The business's revenue for the quarter was up 17.3% on a year-over-year basis. Analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.